LoginSignup
Sam M.
@Sam_Mumm
4Lun·

Newron Pharmaceuticals

34Puestos
137.184,88 €
32,34 %
8
13 Comentarios
Imagen de perfil
Anderlé MPoint@Anderle
4Lun
Looks quite reasonable $NWRN:

+ EV / Sales (5.29)
+ Gross Margin TTM (98.26%)
+ Rule-of-40 Score TTM (432.88%)
+ Sales Growth TTM (467.18%)
+ PEG TTM (0.04)
+ Return on equity LJ (1086.63%)
+ EBIT margin LJ (50.93%)

- Debt ratio (34.68)
- Equity ratio LJ (2.28%) ✌🏻
•
2
•
Imagen de perfil
PiHu@PiHu
4Lun
@Anderle huhu, where did you get the data so quickly? :)
•
1
•
Imagen de perfil
Anderlé MPoint@Anderle
4Lun
@PiHu I'm registered at https://aktien.guide/ (premium account) I think the site is really great and very clear ✌🏻
•
3
•
Sam M.@Sam_Mumm
4Lun
@Anderle There is always the risk that Evenamide will not be approved and then the price will plummet.
•
2
•
Imagen de perfil
Anderlé MPoint@Anderle
4Lun
@Sam_Mumm Correct, the risk exists for all pharmaceutical and biotechnology companies.
•
3
•
FB2plus2is4@FB2plus2is4
1Lun
@Sam_Mumm if everything goes well, is it possible to say when the approval will come? @
••
Sam M.@Sam_Mumm
1Lun
@FB2plus2is4 Q4 2026 is expected, but I would prefer a takeover before then. I recently lost a lot of money on Anavex, as the expected approval did not come.
•
1
•
FB2plus2is4@FB2plus2is4
1Lun
@Sam_Mumm how safe is that at $NWRN? At least in your eyes...
••
Sam M.@Sam_Mumm
1Lun
@FB2plus2is4 There is a big risk with all biotechs, but with Newron I am very sure that we are heading towards CHF 100 the closer we get to approval. The studies are very well prepared, there is even an extra phase II study in the USA. However, I expect a takeover before approval.
•
1
•
FB2plus2is4@FB2plus2is4
1Lun
@Sam_Mumm What exactly would such a takeover mean? I have only recently joined the company. Thanks for the explanation...
••
Sam M.@Sam_Mumm
1Lun
@FB2plus2is4 There are only 22 million shares, and if you offset the share price against this, the MK is still far too low. If we take the two license deals for Japan and South Korea as a basis, we arrive at a market capitalization of around 1.4 billion euros. Further forecasts are difficult, but if you observe the share price and order book, you can come to the conclusion that someone is collecting on a large scale and preparing a takeover. I don't dare to predict at what price. But there is a current valuation of CHF 73. We'll see 🙂
•
1
•
Imagen de perfil
PiHu@PiHu
4Lun
Congratulations, what do they do and how did you find them? 🎈
••
Sam M.@Sam_Mumm
4Lun
@PiHu A small pharmaceutical company from northern Italy. Working on approval for Evenamide, a drug for schizophrenia. But with these small pharmaceutical companies there is always a VERY high risk that the approval will fail. I hope for a takeover beforehand. I work in this field.
•
1
•
Únase a la conversación
InscríbaseInicio de sesión